| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acinic cell carcinoma of the breast: A comprehensive review
|
Ajkunic, Azra
|
|
|
66 |
C |
p. 208-216
|
artikel
|
| 2 |
Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study
|
García-Sánchez, Javier
|
|
|
66 |
C |
p. 310-316
|
artikel
|
| 3 |
Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study
|
Xie, Yuxin
|
|
|
66 |
C |
p. 89-96
|
artikel
|
| 4 |
Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study
|
Sawaki, Masataka
|
|
|
66 |
C |
p. 245-254
|
artikel
|
| 5 |
Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer
|
Rassy, Elie
|
|
|
66 |
C |
p. 217-226
|
artikel
|
| 6 |
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
|
Shastry, Mythili
|
|
|
66 |
C |
p. 169-177
|
artikel
|
| 7 |
Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy
|
Jeong, Jae Ho
|
|
|
66 |
C |
p. 199-203
|
artikel
|
| 8 |
Application of thermoplastic elastomer (TPE) bolus in postmastectomy radiotherapy
|
Gong, Pan
|
|
|
66 |
C |
p. 317-323
|
artikel
|
| 9 |
A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer
|
Jia, Xiaomeng
|
|
|
66 |
C |
p. 31-39
|
artikel
|
| 10 |
Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study
|
Yıldırım, Hasan Çağrı
|
|
|
66 |
C |
p. 85-88
|
artikel
|
| 11 |
Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer
|
Zhou, Jinmei
|
|
|
66 |
C |
p. 255-261
|
artikel
|
| 12 |
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL
|
Longo, Benedetto
|
|
|
66 |
C |
p. 332-341
|
artikel
|
| 13 |
Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
|
Kerin, Eoin P.
|
|
|
66 |
C |
p. 227-235
|
artikel
|
| 14 |
Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer
|
Bahl, Amit
|
|
|
66 |
C |
p. 69-76
|
artikel
|
| 15 |
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib
|
Del Re, Marzia
|
|
|
66 |
C |
p. 157-161
|
artikel
|
| 16 |
Current and future burden of breast cancer: Global statistics for 2020 and 2040
|
Arnold, Melina
|
|
|
66 |
C |
p. 15-23
|
artikel
|
| 17 |
Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer
|
Aapro, Matti
|
|
|
66 |
C |
p. 145-156
|
artikel
|
| 18 |
Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer：A multicenter study
|
Li, Bao
|
|
|
66 |
C |
p. 183-190
|
artikel
|
| 19 |
Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?
|
Jang, Min Kyeong
|
|
|
66 |
C |
p. 1-7
|
artikel
|
| 20 |
Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?
|
Bilani, Nadeem
|
|
|
66 |
C |
p. 49-53
|
artikel
|
| 21 |
Editorial Board
|
|
|
|
66 |
C |
p. i
|
artikel
|
| 22 |
Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3
|
Rugo, Hope S.
|
|
|
66 |
C |
p. 324-331
|
artikel
|
| 23 |
Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment - POLARHIS study
|
Sandor, Mariana-Felicia
|
|
|
66 |
C |
p. 118-125
|
artikel
|
| 24 |
Inclusion of premenopausal women in breast cancer clinical trials
|
Corrigan, Kelsey L.
|
|
|
66 |
C |
p. 204-207
|
artikel
|
| 25 |
Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer
|
Zhao, Xu-Ran
|
|
|
66 |
C |
p. 136-144
|
artikel
|
| 26 |
Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis
|
Bodewes, F.T.H.
|
|
|
66 |
C |
p. 62-68
|
artikel
|
| 27 |
Mondor's disease of the breast: A cutaneous thromboembolic manifestation of Covid-19?
|
Renshaw, Lorna
|
|
|
66 |
C |
p. 305-309
|
artikel
|
| 28 |
Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis
|
Lin, Ying-Yi
|
|
|
66 |
C |
p. 126-135
|
artikel
|
| 29 |
Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis
|
Xu, Yinggang
|
|
|
66 |
C |
p. 8-14
|
artikel
|
| 30 |
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology
|
Miglietta, Federica
|
|
|
66 |
C |
p. 293-304
|
artikel
|
| 31 |
Patterns of care over 10 years in young breast cancer patients in the Netherlands, a nationwide population-based study
|
Maliko, Nansi
|
|
|
66 |
C |
p. 285-292
|
artikel
|
| 32 |
Predictive and prognostic values of tumor infiltrating lymphocytes in breast cancers treated with neoadjuvant chemotherapy: A meta-analysis
|
Li, Shiqi
|
|
|
66 |
C |
p. 97-109
|
artikel
|
| 33 |
Prognosis stratification and postoperative radiation therapy utilization in adenoid cystic carcinoma of the breast
|
Zhang, Di
|
|
|
66 |
C |
p. 40-48
|
artikel
|
| 34 |
Real-world data of HER2-low metastatic breast cancer: A population based cohort study
|
Holthuis, Emily I.
|
|
|
66 |
C |
p. 278-284
|
artikel
|
| 35 |
Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel
|
Mahtani, Reshma
|
|
|
66 |
C |
p. 236-244
|
artikel
|
| 36 |
Reproductive risk factors associated with breast cancer in young women by molecular subtype
|
Ruddy, Kathryn J.
|
|
|
66 |
C |
p. 272-277
|
artikel
|
| 37 |
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
|
Salvador Bofill, Javier
|
|
|
66 |
C |
p. 77-84
|
artikel
|
| 38 |
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy
|
Pedersini, Rebecca
|
|
|
66 |
C |
p. 162-168
|
artikel
|
| 39 |
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study
|
Reinisch, Mattea
|
|
|
66 |
C |
p. 110-117
|
artikel
|
| 40 |
Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/nipple-sparing mastectomy
|
Kim, Nalee
|
|
|
66 |
C |
p. 54-61
|
artikel
|
| 41 |
The impact of standardized structured reporting of pathology reports for breast cancer care
|
Snoek, J.A.A.
|
|
|
66 |
C |
p. 178-182
|
artikel
|
| 42 |
Trastuzumab-based regimens beyond progression: A crucial treatment option for HER2+ advanced/metastatic breast cancer
|
Sanglier, Thibaut
|
|
|
66 |
C |
p. 262-271
|
artikel
|
| 43 |
Trastuzumab deruxtecan versus trastuzumab emtansine for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A cost-effectiveness analysis
|
Zhu, Youwen
|
|
|
66 |
C |
p. 191-198
|
artikel
|
| 44 |
Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysis
|
Sang, Yuting
|
|
|
66 |
C |
p. 24-30
|
artikel
|
Tijdschrift beschrijving